Company Filing History:
1 out of 1,586 
1 out of 1,039 
1 out of 5,450 
Years Active: 2025
Title: Jeremy Rich: Innovator in Glioma Treatment
Introduction
Jeremy Rich is a prominent inventor based in Cleveland, OH (US). He has made significant contributions to the field of medical research, particularly in the treatment of glioblastoma. His innovative approach utilizes Zika virus strains to combat this aggressive form of brain cancer.
Latest Patents
Jeremy Rich holds 1 patent for his work on Zika virus strains for the treatment of glioma. The patent details a composition and method for treating glioblastoma using the Zika virus, showcasing a novel approach to a challenging medical issue.
Career Highlights
Throughout his career, Jeremy has worked with esteemed institutions such as Washington University and The Cleveland Clinic Foundation. His research has focused on developing new therapeutic strategies for glioblastoma, contributing to advancements in cancer treatment.
Collaborations
Jeremy has collaborated with notable colleagues, including Michael S. Diamond and Milan Chheda. Their combined expertise has furthered the understanding and potential treatment options for glioblastoma.
Conclusion
Jeremy Rich's innovative work in utilizing Zika virus strains for glioma treatment represents a significant advancement in cancer research. His contributions continue to inspire new approaches in the fight against glioblastoma.